The FY19 Defense
Appropriation provides $30 million (M) to the Department of Defense Spinal Cord
Injury Research Program (SCIRP)
to support innovative, high-impact spinal cord injury research. As directed by
the Office of the Assistant Secretary of Defense for Health Affairs, the
Defense Health Agency J9, Research and Development Directorate, manages the
Defense Health Program (DHP) Research, Development, Test, and Evaluation
(RDT&E) appropriation. The managing agent for the anticipated Program
Announcements/Funding Opportunities is the Congressionally Directed Medical
Research Programs (CDMRP) at the U.S. Army Medical Research and Materiel
Command (USAMRMC).
FY19 SCIRP Program
Announcements and General Application Instructions for the following award
mechanisms are posted on the Grants.gov website.
For FY19, SCIRP encourages applications
that address the critical needs of SCI research and patient care in one or more
of the following FY19 Focus Areas:
- Neuroprotection
- Biomarkers
- Bladder dysfunction, bowel dysfunction and
neuropathic pain
- Psychosocial issues relevant to
SCI in individuals with SCI or their caregivers
- Rehabilitation and regeneration
Clinical
Trial Award – Preproposal due May 29, 2019
Independent
investigators at all academic levels (or equivalent)
- Fund Phase 0, I, or II clinical trials
with the potential to have a major impact on treatment or management of spinal
cord injury (SCI) and its consequences.
- Applications must include at least two SCI consumer advocates
as members of the research team.
- Preliminary data relevant to the proposed trial required
for all clinical trial applications.
- Pre-application required; application submission is by
invitation only.
- The
maximum allowable funding for the entire period of performance is of $3,
000,000 for direct costs.
- Indirect
costs may be proposed in accordance with the institutions’ negotiated rate
agreement.
- The maximum period of performance is 4 years
Investigator-Initiated
Research Award – Preproposal due May 29, 2019
Independent
investigators at all academic levels (or equivalent)
- Fund SCI-related research that has the
potential to make an important contribution to SCI research and/or patient
care, and/or quality of life.
- Preliminary data required.
- Clinical trials not allowed.
- Pre-application required; application
submission by invitation only.
- The maximum allowable funding for the
entire period of performance is $500,000 for direct costs.
- Indirect costs may be proposed in
accordance with the institution’s negotiated rate agreement.
- The maximum period of performance is 3
years.
Translational
Research Award – Preproposal due May 29, 2019
Independent investigators at all academic
levels (or equivalent)
- Fund studies that accelerate the
movement of promising ideas in SCI research into clinical applications.
- Applications
must include at least one SCI consumer advocate as a member of the research
team.
- Preliminary
data required
- The SCIRP TRA may
include a pilot clinical trial where limited clinical testing of a novel
intervention or device is necessary to inform the next step in the continuum of
translational research.
- Pre-application
required; application submission by invitation only.
- The maximum allowable
funding for the entire period of performance is $1,250,000 for direct
costs.
- Indirect costs may be
proposed in accordance with the institution’s negotiated rate agreement.
- The
maximum period of performance is 3 years
A pre-application is required and must
be submitted through the electronic Biomedical Research Application Portal
(eBRAP) at https://eBRAP.org prior to the pre-application deadline.
All applications must conform to the final Program Announcements and General
Application Instructions available for electronic downloading from the
Grants.gov website. The application package containing the required forms
for each award mechanism is also on Grants.gov. A listing of all CDMRP
and other USAMRMC extramural funding opportunities can be obtained on the
Grants.gov website by performing a basic search using CFDA Number 12.420.
For email notification when Program Announcements are released,
subscribe to program-specific news and updates under “Email Subscriptions” on
the eBRAP homepage at https://eBRAP.org. For more information about the
SCIRP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).
Point of Contact:
CDMRP Help Desk
301-682-5507
help@eBrap.org